Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.

Dean DC 3rd, Jerskey BA, Chen K, Protas H, Thiyyagura P, Roontiva A, O'Muircheartaigh J, Dirks H, Waskiewicz N, Lehman K, Siniard AL, Turk MN, Hua X, Madsen SK, Thompson PM, Fleisher AS, Huentelman MJ, Deoni SC, Reiman EM.

JAMA Neurol. 2014 Jan;71(1):11-22. doi: 10.1001/jamaneurol.2013.4544.

2.

Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Langbaum JB, Chen K, Caselli RJ, Lee W, Reschke C, Bandy D, Alexander GE, Burns CM, Kaszniak AW, Reeder SA, Corneveaux JJ, Allen AN, Pruzin J, Huentelman MJ, Fleisher AS, Reiman EM.

Arch Neurol. 2010 Apr;67(4):462-8. doi: 10.1001/archneurol.2010.30.

3.

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.

Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

Neurobiol Aging. 2014 Sep;35(9):2096-106. doi: 10.1016/j.neurobiolaging.2014.03.006. Epub 2014 Mar 11.

4.

The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.

Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR Jr, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, Schofield PR, Sperling RA, Cairns NJ, Marcus DS, Xiong C, Bateman RJ, Morris JC, Rossor MN, Ourselin S, Fox NC; Dominantly Inherited Alzheimer Network (DIAN).

Neurology. 2013 Oct 15;81(16):1425-33. doi: 10.1212/WNL.0b013e3182a841c6. Epub 2013 Sep 18.

5.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.

PMID:
23146133
6.

Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.

Filippini N, Zarei M, Beckmann CF, Galluzzi S, Borsci G, Testa C, Bonetti M, Beltramello A, Ghidoni R, Benussi L, Binetti G, Frisoni GB.

J Magn Reson Imaging. 2009 May;29(5):1021-6. doi: 10.1002/jmri.21757.

PMID:
19388128
7.

Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.

Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM.

Neurology. 2010 Jan 12;74(2):113-20. doi: 10.1212/WNL.0b013e3181c918cb.

8.

Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.

Yuan Y, Zhang Z, Bai F, You J, Yu H, Shi Y, Liu W.

J Affect Disord. 2010 Mar;121(3):273-7. doi: 10.1016/j.jad.2009.07.003. Epub 2009 Jul 31.

PMID:
19647324
9.

Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.

Nielsen HM, Chen K, Lee W, Chen Y, Bauer RJ 3rd, Reiman E, Caselli R, Bu G.

Alzheimers Res Ther. 2017 Jan 30;9(1):5. doi: 10.1186/s13195-016-0231-9.

10.

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM.

Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003. Epub 2008 Nov 1.

PMID:
19013250
11.

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

Drzezga A, Grimmer T, Henriksen G, Mühlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschläger A, Riemenschneider M, Wester HJ, Foerstl H, Schwaiger M, Kurz A.

Neurology. 2009 Apr 28;72(17):1487-94. doi: 10.1212/WNL.0b013e3181a2e8d0. Epub 2009 Apr 1.

PMID:
19339712
12.

Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.

Pievani M, Rasser PE, Galluzzi S, Benussi L, Ghidoni R, Sabattoli F, Bonetti M, Binetti G, Thompson PM, Frisoni GB.

Neuroimage. 2009 May 1;45(4):1090-8. doi: 10.1016/j.neuroimage.2009.01.009. Epub 2009 Jan 21.

13.

Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.

Alexander GE, Bergfield KL, Chen K, Reiman EM, Hanson KD, Lin L, Bandy D, Caselli RJ, Moeller JR.

Neurobiol Aging. 2012 Dec;33(12):2723-32. doi: 10.1016/j.neurobiolaging.2012.01.014. Epub 2012 Mar 8.

14.

Modulation on brain gray matter activity and white matter integrity by APOE ε4 risk gene in cognitively intact elderly: A multimodal neuroimaging study.

Cai S, Jiang Y, Wang Y, Wu X, Ren J, Lee MS, Lee S, Huang L.

Behav Brain Res. 2017 Mar 30;322(Pt A):100-109. doi: 10.1016/j.bbr.2017.01.027. Epub 2017 Jan 17.

PMID:
28108320
15.

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, Morris CM, O'Brien JT.

Arch Neurol. 1999 Aug;56(8):961-5.

PMID:
10448801
16.

Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.

Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM.

J Alzheimers Dis. 2010;22(1):307-13. doi: 10.3233/JAD-2010-100129.

17.

The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease.

Kljajevic V, Meyer P, Holzmann C, Dyrba M, Kasper E, Bokde AL, Fellgiebel A, Meindl T, Hampel H, Teipel S; EDSD study group.

Alzheimers Dement. 2014 May;10(3):401-4. doi: 10.1016/j.jalz.2013.02.008. Epub 2013 May 21.

PMID:
23706516
18.

Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.

Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S, Truran-Sacrey D, Schuff N, Weiner MW, Caselli RJ, Reiman EM.

JAMA Neurol. 2013 Mar 1;70(3):320-5.

19.

Age-related differences in white matter integrity and cognitive function are related to APOE status.

Ryan L, Walther K, Bendlin BB, Lue LF, Walker DG, Glisky EL.

Neuroimage. 2011 Jan 15;54(2):1565-77. doi: 10.1016/j.neuroimage.2010.08.052. Epub 2010 Sep 6.

20.

The neuroanatomical substrate of lexical-semantic decline in MCI APOE ε4 carriers and noncarriers.

Venneri A, McGeown WJ, Biundo R, Mion M, Nichelli P, Shanks MF.

Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):230-41. doi: 10.1097/WAD.0b013e318206f88c.

PMID:
21192234

Supplemental Content

Support Center